A new medicine R&D engine (R&D pharma company) operated by an experienced team dedicated to the discovery and development of new medicines to treat patient suffering from severe diseases of the central nervous system.
Accure Therapeutics focuses on neurons that suffer a dysfunction, and on the glial environment that supports them, in an attempt to impede their degeneration and death. We work to find new medicines that correct the pathological changes that are responsible for the disease, and that produce beneficial outcomes (i.e. Disease Modifying Therapies). We specialize in developing drugs that promote neuroprotection and neurorepair by integrating the latest advances in neurobiology with state-of-the-art clinical research.
We have currently built up a drug candidate portfolio that focuses on four areas: Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease and Epilepsy.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2020
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Accure Therapeutics founded?
Accure Therapeutics was founded in 2020.
What industry is Accure Therapeutics in?
Accure Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Accure Therapeutics based?
Accure Therapeutics is headquartered in Barcelona, Spain.
Find investors for your startup like Accure Therapeutics
Gritt sends AI-personalised outreach to each investor — from your Gmail